Pfizer and BioNTech Coronavirus Vaccine Accepted for Rolling Review in Canada

The coronavirus vaccine candidate being developed by Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) is now undergoing its first regulatory review in North America. The two companies announced that their BNT162b2 has been accepted for a rolling review by Health Canada, that country's healthcare regulatory authority.